A novel biomarker-guided immunomodulatory approach for the therapy of sepsis
- PMID: 19762591
- DOI: 10.1164/rccm.200907-1095ED
A novel biomarker-guided immunomodulatory approach for the therapy of sepsis
Comment on
-
Granulocyte-macrophage colony-stimulating factor to reverse sepsis-associated immunosuppression: a double-blind, randomized, placebo-controlled multicenter trial.Am J Respir Crit Care Med. 2009 Oct 1;180(7):640-8. doi: 10.1164/rccm.200903-0363OC. Epub 2009 Jul 9. Am J Respir Crit Care Med. 2009. PMID: 19590022 Clinical Trial.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical